Octagos Health's latest lobbying report covers Q1 2024, at under $5,000. Its first report covers Q2 2022; the issues it reports most are Medical/Disease Research/Clinical Labs.

Octagos Health

Latest quarter: No record; Q3 2026 · 0 reports
Last 12 months: $0; Last 4 quarters
vs last quarter: No record; Q3 2026 against the quarter before
First report: Q2 2022; The first quarter a report named it

Lobbying by quarter

Octagos Health lobbying by quarter
Quarter	Amount	Reports
Q2 2022	$10K	1
Q3 2022	$0	0
Q4 2022	$10K	1
Q1 2023	$0	1
Q2 2023	$0	1
Q3 2023	$0	1
Q4 2023	$0	1
Q1 2024	$0	1
Q2 2024	$0	0
Q3 2024	$0	0
Q4 2024	$0	0
Q1 2025	$0	0
Q2 2025	$0	0
Q3 2025	$0	0
Q4 2025	$0	0
Q1 2026	$0	0
Q2 2026	$0	0
Q3 2026	$0	0

By issue

Medical research and clinical labs$20K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

Health & Human Services, Dept of (HHS)2 reports
HOUSE OF REPRESENTATIVES2 reports
SENATE2 reports

Firms it paid

Firm
Foley & Lardner	$20K	7 quarters

Former officials lobbying for it

	Former position	Firm
JARED RIFIS	Legislative Correspondent, Legislative Aide; Legislative Assistant: Sen. Harry Reid	Foley & Lardner	Q4 2022
JENNIFER FITZGERALD WALSH	AA; Deputy COS, COS: Rep. Dennis Cardoza; Field Representative: Rep. Vic Fazio; Staff Asst, Program Dir, EA: House Democratic Caucus	Foley & Lardner	Q4 2022
WILLIAM BALL	Sen. Susan Collins, 2010-2015; House Committee on Natural Resources, 2015-2020	Foley & Lardner	Q4 2022

Lobbying reports

	Filed by		Issues
24/04/19for Q1 2024	Foley & Lardner	Under $5,000
24/01/21for Q4 2023	Foley & Lardner	Under $5,000
23/10/19for Q3 2023	Foley & Lardner	Under $5,000
23/07/20for Q2 2023	Foley & Lardner	Under $5,000
23/04/20for Q1 2023	Foley & Lardner	Under $5,000
23/01/20for Q4 2022	Foley & Lardner	$10K	Medical research and clinical labs
23/01/04for Q2 2022	Foley & Lardner	$10K	Medical research and clinical labs